Search results
Pfizer Agrees to Settle More than 10,000 Zantac Cancer Lawsuits
Bloomberg Law· 11 hours agohas agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of its Zantac heartburn drug, according to people familiar with the deal, the biggest of the litigation. The ...
Is Pfizer Stock Fully Valued At $28?
Forbes· 2 days agoPfizer (NYSE: PFE) reported its Q1 results last week, with revenues and earnings beating the street estimates.
Pfizer Agrees to Settle More than 10,000 Zantac Cancer Lawsuits
Bloomberg· 11 hours agoPfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of...
Pfizer Agrees to Settle More Than 10,000 Zantac Cancer Lawsuits
Insurance Journal· 9 hours agoPfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of...
Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports By Reuters
Investing.com· 10 hours agoThe agreements cover cases in U.S. state courts but don't completely resolve the company's exposure...
Pfizer agrees to settle over 10,000 Zantac lawsuits
New Hampshire Union Leader· 10 hours agoPfizer has agreed to settle more than 10,000 lawsuits about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported...
Pfizer agrees to settle more than 10,000 Zantac cancer lawsuits - Bloomberg News
Reuters via Yahoo Finance· 10 hours agoMay 8 (Reuters) - Pfizer Inc has agreed to settle more than 10,000 cases about cancer risks related to the now discontinued heartburn drug Zantac, Bloomberg News reported ...
Pfizer Pauses Gene Therapy Trial for Muscle Disease After Death
Bloomberg· 1 day agoPfizer Inc. paused a study of an experimental gene therapy for muscular dystrophy after a child who...
Pfizer reports patient death in Duchenne gene therapy study
Reuters via Yahoo News· 1 day ago(Reuters) -A young patient died due to cardiac arrest after receiving Pfizer's experimental gene...
Pfizer reports fatality in Phase II DMD gene therapy study
Clinical Trials Arena via Yahoo Finance· 14 hours agoPfizer has reported the death of a patient in the Phase II DAYLIGHT study of experimental gene...